CANOQ — Cano Health Cashflow Statement
0.000.00%
- $1.30m
- -$112.75m
- $3.14bn
- 40
- 54
- 14
- 29
Annual cashflow statement for Cano Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16.2 | -74.8 | -117 | -428 | -1,099 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 3.57 | 51.2 | -47.9 | 315 | 536 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -9.64 | -4.13 | -13.3 | -123 | 247 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -15.5 | -9.23 | -129 | -146 | -129 |
Capital Expenditures | -9.31 | -12.1 | -34.4 | -49.5 | -19.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -81.5 | -256 | -1,097 | -14.6 | 30.2 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -90.8 | -268 | -1,131 | -64.2 | 11 |
Financing Cash Flow Items | -0.762 | -59.1 | 929 | -0.966 | -8.88 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 132 | 282 | 1,389 | 74.7 | 167 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 25.8 | 4.62 | 129 | -136 | 48.4 |